12.01.22|Meir OrbachThe IT management company raised the sum in two rounds over a month-and-a-half in late 2021
19.05.20|Hagar RavetThe companies are in ongoing discussions concerning the timing and terms of completion, but, according to ForeScout, there can be no assurance that they could reach an agreement
15.08.17|CalcalistThe private equity firms are taking an interest in Teva's European oncology and pain treatment assets, estimated at $700 million to 1$ billion, according to a Bloomberg report